American College of Rheumatology 2010 recommendations for the prevention and treatment of glucocorticoid‐induced osteoporosis
Top Cited Papers
Open Access
- 2 November 2010
- journal article
- review article
- Published by Wiley in Arthritis Care & Research
- Vol. 62 (11), 1515-1526
- https://doi.org/10.1002/acr.20295
Abstract
No abstract availableThis publication has 88 references indexed in Scilit:
- FRAX® and its applications to clinical practiceBone, 2009
- Enhancing access to reports of randomized trials published world-wide – the contribution of EMBASE records to the Cochrane Central Register of Controlled Trials (CENTRAL) in The Cochrane LibraryEmerging Themes in Epidemiology, 2008
- Will My Patient Fall?Jama-Journal Of The American Medical Association, 2007
- Risedronate, an effective treatment for glucocorticoid-induced bone loss in CKD patients with or without concomitant active vitamin D (PRIUS-CKD)Nephrology Dialysis Transplantation, 2006
- Alendronate or Alfacalcidol in Glucocorticoid-Induced OsteoporosisThe New England Journal of Medicine, 2006
- Developing Quality Indicators for Elderly Patients Undergoing Abdominal OperationsJournal of the American College of Surgeons, 2005
- Osteoporosis and Fracture Risk in Women of Different Ethnic GroupsJournal of Bone and Mineral Research, 2005
- Cyclical etidronate in the prevention of bone loss in corticosteroid-treated primary biliary cirrhosis: A prospective, controlled pilot studyJournal of Hepatology, 1997
- Assessing the quality of reports of randomized clinical trials: Is blinding necessary?Controlled Clinical Trials, 1996
- Vertebral fracture assessment using a semiquantitative techniqueJournal of Bone and Mineral Research, 1993